HMCIB SPAC 3 (226340) — Capital Reinvestment Ratio
HMCIB SPAC 3 (226340) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow (₩2.56 Billion) in capital expenditures (₩7.51 Million). See free cash flow generation of HMCIB SPAC 3 to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HMCIB SPAC 3 Capital Reinvestment Ratio (2017–2023)
This chart tracks HMCIB SPAC 3's Capital Reinvestment Ratio across 5 annual periods. See 226340 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Capital Reinvestment Ratio for HMCIB SPAC 3 (2017–2023)
Year-by-year Capital Reinvestment Ratio for HMCIB SPAC 3 from 2017 to 2023. For the full cash flow conversion analysis, see 226340 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | ₩4.61 Billion | ₩166.07 Million | ▼ -99.7% |
| 2021 | 11.91x | ₩2.05 Billion | ₩24.41 Billion | ▲ +7681.8% |
| 2020 | 0.15x | ₩2.98 Billion | ₩456.34 Million | ▲ +1777.0% |
| 2019 | 0.01x | ₩9.98 Billion | ₩81.36 Million | ▼ -73.2% |
| 2017 | 0.03x | ₩3.02 Billion | ₩92.08 Million | — |